Frontiers in Systems Biology,
Journal Year:
2024,
Volume and Issue:
4
Published: June 7, 2024
The
COVID-19
pandemic
generated
large
amounts
of
data
on
the
disease
pathogenesis
leading
to
a
need
for
organizing
vast
knowledge
in
succinct
manner.
Between
April
2020
and
February
2023,
CIAO
consortium
exploited
Adverse
Outcome
Pathway
(AOP)
framework
comprehensively
gather
systematically
organize
published
scientific
literature
pathology.
project
considered
24
pathways
relevant
by
identifying
essential
key
events
(KEs)
19
adverse
outcomes
observed
patients.
While
an
individual
AOP
defines
causally
linked
perturbed
KEs
towards
outcome,
building
network
visually
reflect
interrelatedness
various
outcomes.
In
this
study,
17
those
AOPs
were
selected
based
quality
criteria
computationally
derive
network.
This
primary
highlighted
consider
tissue
specificity
helped
identify
missing
or
redundant
elements
which
then
manually
implemented
final
Such
enabled
visualization
complex
interactions
multifaceted
confirmed
central
role
inflammatory
response
disease.
addition,
study
disclosed
importance
terminology
harmonization
tissue/organ
building.
Furthermore
unequal
completeness
information
contained
tighter
implementation
FAIR
principles
improve
findability,
accessibility,
interoperability
re-usability.
Finally,
underlined
that
describing
specific
SARS-CoV-2
replication
discriminating
physiological
from
pathological
inflammation
is
necessary
but
requires
adaptations
framework.
Hence,
challenges
encountered,
we
proposed
recommendations
ongoing
future
AOP-aligned
consortia
aiming
build
biologically
meaningful
networks
context
of,
not
limited
to,
viral
diseases.
Human Genomics,
Journal Year:
2023,
Volume and Issue:
17(1)
Published: July 24, 2023
Abstract
Three
and
a
half
years
after
the
pandemic
outbreak,
now
that
WHO
has
formally
declared
emergency
is
over,
COVID-19
still
significant
global
issue.
Here,
we
focus
on
recent
developments
in
genetic
genomic
research
COVID-19,
give
an
outlook
state-of-the-art
therapeutical
approaches,
as
gradually
transitioning
to
endemic
situation.
The
sequencing
characterization
of
rare
alleles
different
populations
made
it
possible
identify
numerous
genes
affect
either
susceptibility
or
severity
disease.
These
findings
provide
beginning
new
avenues
pan-ethnic
therapeutic
well
potential
screening
protocols.
causative
virus,
SARS-CoV-2,
spotlight,
but
novel
threatening
virus
could
appear
anywhere
at
any
time.
Therefore,
continued
vigilance
further
warranted.
We
also
note
emphatically
prevent
future
pandemics
other
world-wide
health
crises,
imperative
capitalize
what
have
learnt
from
COVID-19:
specifically,
regarding
its
origins,
world’s
response,
insufficient
preparedness.
This
requires
unprecedented
international
collaboration
timely
data
sharing
for
coordination
effective
response
rapid
implementation
containment
measures.
Toxicological Sciences,
Journal Year:
2023,
Volume and Issue:
192(2), P. 155 - 177
Published: Feb. 14, 2023
Globally,
industries
and
regulatory
authorities
are
faced
with
an
urgent
need
to
assess
the
potential
adverse
effects
of
chemicals
more
efficiently
by
embracing
new
approach
methodologies
(NAMs).
NAMs
include
cell
tissue
methods
(in
vitro),
structure-based/toxicokinetic
models
silico),
that
toxicant
interactions
biological
macromolecules
chemico),
alternative
models.
Increasing
knowledge
on
chemical
toxicokinetics
(what
body
does
chemicals)
toxicodynamics
do
body)
obtained
from
in
silico
vitro
systems
continues
provide
opportunities
for
modernizing
risk
assessments.
However,
directly
leveraging
data
derivation
human
health-based
reference
values
has
not
received
acceptance
due
uncertainties
extrapolating
NAM
results
populations,
including
metabolism,
complex
pathways,
multiple
exposures,
interindividual
susceptibility
vulnerable
populations.
The
objective
this
article
is
a
standardized
pragmatic
framework
applies
integrated
approaches
focus
quantitative
vivo
extrapolation
(QIVIVE)
extrapolate
cellular
exposures
equivalent
doses
which
can
be
derived.
proposed
intends
systematically
account
complexities
interpretation
support
sound
health
safety
decisions
diverse
industrial
sectors
(food
systems,
cosmetics,
chemicals,
pharmaceuticals
etc.).
Case
studies
entities,
using
existing
data,
presented
demonstrate
utility
while
highlighting
sources
population
bias
uncertainty,
importance
Good
Method
Reporting
Practices.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(18), P. 5400 - 5400
Published: Sept. 14, 2022
Alteration
in
gut
microbiota
has
been
associated
with
COVID-19.
However,
the
underlying
mechanisms
remain
poorly
understood.
Here,
we
outlined
three
potential
interconnected
mechanistic
pathways
leading
to
dysbiosis
as
an
adverse
outcome
following
SARS-CoV-2
presence
gastrointestinal
tract.
Evidence
from
literature
and
current
uncertainties
are
reported
for
each
step
of
different
pathways.
One
pathway
investigates
evidence
that
intestinal
infection
by
inducing
inflammation
alters
microbiota.
Another
links
binding
viral
S
protein
angiotensin-converting
enzyme
2
(ACE2)
dysregulation
this
receptor,
essential
homeostasis—notably
amino
acid
metabolism—leading
dysbiosis.
Additionally,
could
induce
infecting
bacteria.
Assessing
within
Adverse
Outcome
Pathway
framework
justifies
confidence
proposed
support
disease
management
permits
identification
inconsistencies
knowledge
gaps
orient
further
research.
Scientific Data,
Journal Year:
2023,
Volume and Issue:
10(1)
Published: June 24, 2023
Adverse
outcome
pathways
(AOPs)
are
emerging
as
a
central
framework
in
modern
toxicology
and
other
fields
biomedicine.
They
serve
an
extension
of
pathway-based
concepts
by
depicting
biological
mechanisms
causally
linked
sequences
key
events
(KEs)
from
molecular
initiating
event
(MIE)
to
adverse
outcome.
AOPs
guide
the
use
development
new
approach
methodologies
(NAMs)
aimed
at
reducing
animal
experimentation.
While
model
systemic
various
levels
organisation,
toxicogenomics
provides
means
study
chemical
exposures.
Systematic
integration
these
two
would
improve
application
AOP-based
knowledge
while
also
supporting
interpretation
complex
omics
data.
Hence,
we
established
this
link
through
rigorous
curation
annotations
for
KEs
human
relevant
AOPs.
We
further
expanded
consolidated
context
KEs.
These
curated
pave
way
embed
data
interpretation,
facilitating
emergence
Environmental Research,
Journal Year:
2023,
Volume and Issue:
223, P. 115419 - 115419
Published: Feb. 4, 2023
There
is
wide,
largely
unexplained
heterogeneity
in
immunological
and
clinical
responses
to
SARS-CoV-2
infection.
Numerous
environmental
chemicals,
such
as
persistent
organic
pollutants
(POPs)
chemical
elements
(including
some
metals,
essential
trace
elements,
rare
earth
minority
elements),
are
immunomodulatory
cause
a
range
of
adverse
events.
no
prospective
studies
on
the
effects
substances
incidence
infection
COVID-19.To
investigate
influence
blood
concentrations
POPs
measured
several
years
before
pandemic
development
COVID-19
individuals
from
general
population.We
conducted
cohort
study
154
population
Barcelona.
were
samples
collected
2016-2017.
was
detected
by
rRT-PCR
nasopharyngeal
swabs
and/or
antibody
serology
using
eighteen
isotype-antigen
combinations
2020-2021.
We
analyzed
associations
between
contaminants
COVID-19,
taking
into
account
personal
habits
living
conditions
during
pandemic.Several
historically
prevalent
POPs,
well
arsenic,
cadmium,
mercury,
zinc,
not
associated
with
nor
However,
DDE
(adjusted
OR
=
5.0
[95%
CI:
1.2-21]),
lead
(3.9
[1.0-15]),
thallium
(3.4
[1.0-11]),
ruthenium
(5.0
[1.8-14])
tantalum,
benzo(b)fluoranthene,
DDD,
manganese.
Thallium
(3.8
[1.6-8.9]),
(2.9
[1.3-6.7])
infection,
so
lead,
gold,
(protectively)
iron
selenium.
identified
mixtures
up
five
groups,
all
independently
outcomes.Our
results
provide
first
population-based
evidence
an
association
individual
may
contribute
explain
population.
If
confirmed
causal,
means
available
mitigate
corresponding
risks.
Environmental Research,
Journal Year:
2023,
Volume and Issue:
228, P. 115907 - 115907
Published: April 18, 2023
As
a
pandemic
hotspot
in
Japan,
between
March
1,
2020–October
2022,
Tokyo
metropolis
experienced
seven
COVID-19
waves.
Motivated
by
the
high
rate
of
incidence
and
mortality
during
seventh
wave,
environmental/health
challenges
we
conducted
time-series
analysis
to
investigate
long-term
interaction
air
quality
climate
variability
with
viral
Tokyo.
Through
daily
time
series
geospatial
observational
pollution/climate
data,
death
cases,
this
study
compared
environmental
conditions
multiwaves.
In
spite
five
State
Emergency
(SOEs)
restrictions
associated
pandemic,
(2020–2022)
period
recorded
low
improvements
relative
(2015–2019)
average
annual
values,
namely:
Aerosol
Optical
Depth
increased
9.13%
2020
year,
declined
6.64%
2021,
12.03%
2022;
particulate
matter
PM2.5
PM10
decreased
2020,
2022
years
10.22%,
62.26%,
0.39%,
respectively
4.42%,
3.95%,
5.76%.
For
(2021–2022)
ratio
PM2.5/PM10
was
(0.319
±
0.1640),
showing
higher
contribution
aerosol
loading
traffic-related
coarse
particles
comparison
fine
particles.
The
highest
rates
cases
wave
(1
July
2022–1
October
2022)
may
be
attributed
accumulation
near
ground
levels
pollutants
pathogens
due
to:
1)
peculiar
persistent
atmospheric
anticyclonic
circulation
strong
positive
anomalies
geopotential
height
at
500
hPa;
2)
lower
Planetary
Boundary
Layer
(PBL)
heights;
3)
maximum
temperature
land
surface
prolonged
heat
waves
(HWs)
summer
4)
no
imposed
restrictions.
Such
findings
can
guide
public
decision-makers
design
proper
strategies
curb
pandemics
under
stable
weather
HWs
large
metropolitan
areas.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(19), P. 5691 - 5691
Published: Sept. 26, 2022
The
gut
has
been
proposed
as
a
potential
alternative
entry
route
for
SARS-CoV-2.
This
was
mainly
based
on
the
high
levels
of
SARS-CoV-2
receptor
expressed
in
gastrointestinal
(GI)
tract,
observations
GI
disorders
(such
diarrhea)
some
COVID-19
patients
and
detection
RNA
feces.
However,
underlying
mechanisms
remain
poorly
understood.
It
that
can
productively
infect
enterocytes,
damaging
intestinal
barrier
contributing
to
inflammatory
response,
which
might
lead
manifestations,
including
diarrhea.
Here,
we
report
methodological
approach
assess
evidence
supporting
sequence
events
driving
enteric
infection
up
adverse
outcomes.
Exploring
permits
highlight
knowledge
gaps
current
inconsistencies
literature
guide
further
research.
Based
insights
transmission,
then
discuss
implication
clinical
practice,
long
COVID.
A
better
understanding
is
still
needed
improve
disease
management
could
help
identify
innovative
therapies
or
preventive
actions
targeting
tract.
Cells,
Journal Year:
2022,
Volume and Issue:
11(19), P. 3027 - 3027
Published: Sept. 27, 2022
Loss
of
the
sense
smell
(anosmia)
has
been
included
as
a
COVID-19
symptom
by
World
Health
Organization.
The
majority
patients
recover
within
few
weeks
postinfection
(short-term
anosmia),
while
others
report
persistent
anosmia.
Several
studies
have
investigated
mechanisms
leading
to
anosmia
in
COVID-19;
however,
evidence
is
scattered,
and
remain
poorly
understood.
Based
on
comprehensive
review
literature,
we
aim
here
evaluate
current
knowledge
uncertainties
regarding
short-term
following
SARS-CoV-2
infection.
We
applied
an
adverse
outcome
pathway
(AOP)
framework,
well
established
toxicology,
propose
sequence
measurable
key
events
(KEs)
COVID-19.
Those
KEs
are
(1)
Spike
proteins
binding
ACE-2
expressed
sustentacular
(SUS)
cells
olfactory
epithelium
(OE);
(2)
viral
entry
into
SUS
cells;
(3)
replication
(4)
cell
death;
(5)
damage
sensory
neurons
(OE).
This
AOP-aligned
approach
allows
for
identification
gaps
where
more
research
should
be
conducted
therapeutic
intervention
could
act.
Finally,
this
AOP
gives
frame
explain
several
disease
features
can
linked
specific
factors
that
lead
interindividual
differences
response
Alternatives to Laboratory Animals,
Journal Year:
2023,
Volume and Issue:
51(4), P. 263 - 288
Published: June 6, 2023
Animal
experimentation
has
been
integral
to
drug
discovery
and
development
safety
assessment
for
many
years,
since
it
provides
insights
into
the
mechanisms
of
efficacy
toxicity
(e.g.
pharmacology,
pharmacokinetics
pharmacodynamics).
However,
due
species
differences
in
physiology,
metabolism
sensitivity
drugs,
animal
models
can
often
fail
replicate
effects
drugs
chemicals
human
patients,
workers
consumers.
Researchers
across
globe
are
increasingly
applying
Three
Rs
principles
by
employing
innovative
methods
research
testing.
The
concept
focuses
on:
replacement
with
vitro
silico
or
studies),
on
reduction
number
animals
required
achieve
objectives,
refinement
existing
experimental
practices
eliminating
distress
enhancing
wellbeing).
For
last
two
Oncoseek
Bio-Acasta
Health,
a
3-D
cell
culture-based
cutting-edge
translational
biotechnology
company,
organised
an
annual
International
Conference
3Rs
Research
Progress.
This
series
global
conferences
aims
bring
together
researchers
diverse
expertise
interests,
platform
where
they
share
discuss
their
promote
according
principles.
In
November
2022,
3rd
international
conference,
Advances
Models
Cutting-Edge
Alternatives,
took
place
at
GITAM
University
Vishakhapatnam
(AP,
India)
hybrid
format
(i.e.
online
in-person).
These
conference
proceedings
provide
details
presentations,
which
were
categorised
under
five
different
topic
sessions.
It
also
describes
special
interactive
session
strategies
preclinical
oncology,
was
held
end
first
day.